Table 4.

Table summarizing the human studies evaluated in this review article.

Human studies
Year	Author	Cannabinoid type	Findings
2018	Chelliah et al. 45	Topical CBD	Case series: patients with epidermolysis bullosa had improved symptoms
2019	Palmieri et al. 46	Topical CBD	Retrospective review: patients with various cutaneous disorders had improved symptoms
2020	Maida et al. 47	Topical CBD, terpenes, and flavonoids	Prospective cohort study: patients with nonuremic calciphylaxis leg ulcers who failed other treatments had a good response
2021	Maida et al. 48	Topical CBD, terpenes, and flavonoids	Prospective cohort study: patients with venous leg ulcers who failed other treatments had a good response
2021	Diaz et al. 49	Oral THC and CBD oils	Case report: patient with pressure ulcer refractory to treatment for 5 years improved incidentally after starting CBD and THC oil
2021	Schrader et al. 50	Topical, oral, and inhaled cannabinoids	Cross‐sectional survey: patients with epidermolysis bullosa had improvement in their symptoms